Michal Oleksiejczuk has accepted a one-year sanction for a violation of the UFC Anti-Doping Policy per a USADA release on Tuesday. His victory over Khalil Rountree was overturned by the Nevada Athletic Commission after testing positive for a banned substance.
It was the light heavyweight’s first fight with the UFC. And now, the 23-year-old will have to wait until December 2018 to return to the UFC. The Polish fighter was flagged for an in-competition test.
Per USADA press release:
Oleksiejczuk, 23, tested positive for clomiphene following an in-competition urine test conducted on December 30, 2017, at UFC 219 in Las Vegas, Nev. Clomiphene is a Specified Substance in the category of Hormone and Metabolic Modulators and is prohibited at all times under the UFC Anti-Doping Policy, which has adopted the WADA Prohibited List.
Oleksiejczuk’s one-year period of ineligibility began on December 30, 2017, the date his positive sample was collected, and is identical in length to the sanction imposed by the Nevada State Athletic Commission (NSAC) on March 13, 2018. In addition, the NSAC overturned Oleksiejczuk’s victory at UFC 219 to a no-contest.
Payout Perspective:
At only 23, the sanction does not detour his career too much although a year away from the organization could hurt. He had made $12,000 and $12,000 to win according to Nevada Athletic Commission pay disclosures. It’s not clear whether Oleksiejczuk will have to return the pay due to the overturn to a no-decision.
Leave a Reply